Brief: Avalo Therapeutics Appoints Michael Heffernan As Chairman Of The Board
March 26 (Reuters) - Avalo Therapeutics Inc AVTX.O: AVALO THERAPEUTICS APPOINTS MICHAEL HEFFERNAN AS CHAIRMAN OF THE BOARD AVALO THERAPEUTICS - GARRY NEIL TO REMAIN AS CEO AND BOARD MEMBER Source text: ID:nGNX8mG9R Further company coverage: AVTX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Trevi Therapeutics
See all newsTrevi Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Trevi Therapeutics Q2 net loss widens on higher R&D costs
Brief: Trevi Therapeutics Q2 Net Income USD -17.797 Million
Trevi Therapeutics Q1 net loss widens as R&D costs rise
Brief: Trevi Therapeutics Q1 Net Income USD -13.192 Million